The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are subthreshold, voltage-gated ion channels that are highly expressed in hippocampal and cortical pyramidal cell dendrites, where they are important for regulating synaptic potential integration and plasticity. We found that HCN1 subunits are also localized to the active zone of mature asymmetric synaptic terminals targeting mouse entorhinal cortical layer III pyramidal neurons. HCN channels inhibited glutamate synaptic release by suppressing the activity of low-threshold voltage-gated T-type (Ca V 3.2) Ca 2+ channels. Consistent with this, electron microscopy revealed colocalization of presynaptic HCN1 and Ca V 3.2 subunit. This represents a previously unknown mechanism by which HCN channels regulate synaptic strength and thereby neural information processing and network excitability.
a r t I C l e S HCN channels are low-threshold, voltage-gated ion channels with very unusual biophysical properties 1 . These channels are open at potentials more negative to -50 mV and are important for regulating neuronal resting membrane potential (RMP). In addition, the channels are permeable to Na + and K + and form an inward current at rest, thereby depolarizing the RMP. Notably, in the hippocampus and cortex, they are highly localized to pyramidal cell dendrites 2, 3 . By regulating the RMP, and in this way the biophysical properties of other ion channels as well as by modulating the membrane resistance, they influence excitatory postsynaptic potential (EPSP) kinetics and integration [4] [5] [6] [7] . These effects are likely to substantially contribute to synaptic plasticity and processes such as information storage [8] [9] [10] [11] [12] . Indeed, a reduction in HCN channel expression has been associated with enhanced learning 8,9 . Emerging evidence, however, suggests that, in addition to their dendritic localization, HCN channels may be present on certain axons and synaptic terminals in the hippocampus, cortex and other regions of the brain 3, [13] [14] [15] . Indeed, it has been suggested that presynaptic HCN channel current, I h , affects inhibitory synaptic transmission in the rodent cerebellum, hippocampus and basal ganglia 14, 16, 17 , although the mechanism by which this occurs is unknown. However, in contrast to what is seen for invertebrate neurons 18, 19 , an explicit role for I h in regulating mammalian excitatory basal synaptic transmission has not yet been revealed. This is despite HCN subunit expression being detected in some immature glutamatergic pathways 13 and functional I h being recorded from immature synaptic terminals in the calyx of Held 20 . We found that HCN1 channels are present at the active zone of mature glutamatergic cortical synaptic terminals establishing contact with entorhinal cortical layer III cells, where they decreased neurotransmission by restricting Ca 2+ entry via presynaptic T-type (Ca V 3.2) Ca 2+ channels. Given that changes in synaptic strength are pivotal to induction and maintenance of synaptic plasticity 21 and that entorhinal cortical layer III neurons are likely to be involved in memory formation and spatial navigation 22, 23 , our results indicate that this is a previously unknown mechanism by which HCN1 subunits may contribute to such physiological processes.
RESULTS

HCN channels alter glutamate release onto layer III cells
Synaptic release is important for regulating individual neuronal as well as neural network excitability. Thus, elucidating the factors modulating synaptic transmission is critical for understanding how neural circuits function. Previously 4 , we observed that a loss of I h enhanced synaptic transmission onto mature entorhinal cortical layer III pyramidal neurons, the principal cell type in layer III 24 . This is likely to have been, at least partly, a result of enhanced feedforward excitation resulting from pyramidal cell hyperexcitability. However, as HCN subunits may be present at certain synaptic terminals [13] [14] [15] [16] [17] 20 , it is possible that this effect could be a result of changes in synaptic release per se by modified presynaptic HCN channel activity.
To test this, we initially recorded non-evoked miniature excitatory postsynaptic currents (mEPSC) in the presence of tetrodotoxin (1 µM) and GABA receptor inhibitors at a fixed potential of −70 mV from mouse entorhinal cortical layer III neurons (Fig. 1a) using the whole-cell voltage-clamp technique (as described previously 14, 16, 17 , see Online Methods). To exclude the effects of postsynaptic HCN channels 12 and to reduce errors resulting from space clamp 25 , we used 15 µM ZD7288 in the patch pipette in all of our experiments unless otherwise stated. Intracellular ZD7288 enhanced the outward holding current, indicating that the postsynaptic neuronal RMP was hyperpolarized (Supplementary Table 1 ). The mEPSC rise and decay times were also slowed, as would be expected by blocking postsynaptic HCN channels (see refs. 4,5,24) . Including ZD7288 in the patch pipette, however, had no effect on mEPSC frequency, indicating this did not affect synaptic a r t I C l e S release per se ( Supplementary Table 1 ). Further, substituting KMeSO 4 with CsMeSO 4 in the intracellular solution did not alter either somatic or dendritic mEPSC frequency, amplitude and kinetics (Supplementary Table 1 ), indicating that the errors resulting from space clamp were not reduced further by blocking postsynaptic K + channels 25 .
To determine whether functional HCN channels are present presynaptically, we bath-applied ZD7288 (15 µM) for only 15 min to exclude any potential nonspecific effects of the compound on synaptic transmission 26 . This concentration was deemed specific, as it enhances wild-type dendritic excitability while having little effect on Hcn1 −/− dendrites (see ref. 4) . Notably, external application of ZD7288 enhanced wild-type somatic mEPSC frequency by 113.8 ± 19.1% (n = 7, P < 0.01; Fig. 1b) . The outward holding current as well as mEPSC amplitude, rise times and decay time constants were not further affected ( Fig. 1b) . Furthermore, 15-min external application of another I h blocker, zatebradine 27,28 (10 µM), also enhanced mEPSC frequency in a comparable manner without affecting amplitude or kinetics ( Supplementary Fig. 1a ). In these experiments, ZD7288 was included in the internal patch pipette solution. However, even when this was not present in the internal solution, external application of ZD7288 still amplified wild-type mEPSC frequency by 108.3 ± 14.8% (n = 6). In these experiments, the decay time constant increased significantly from 7.9 ± 0.6 (n = 6) to 10.0 ± 0.5 (n = 6, P < 0.05), as would be predicted by blocking postsynaptic HCN channels.
Because dendrites receive the majority of excitatory synaptic inputs 29 , we also recorded mEPSCs from entorhinal cortical layer III apical dendrites at a distance of 120-150 µm from the soma (Fig. 1c) . The frequency, but not amplitude or kinetics, of dendritic mEPSCs was increased by application of ZD7288 by 69.7 ± 5.3% (n = 5; Fig. 1c ). This effect was not significantly different (P = 0.1) to that observed at the soma. This indicates that synapses targeting entorhinal cortical layer III neurons contain presynaptic I h .
HCN1 subunits are likely to be predominantly expressed in the entorhinal cortex 3, 4 . We therefore compared Hcn1 −/− and wild-type mEPSCs recorded from layer III neurons. As ZD7288 was present in the internal pipette solution, wild-type and Hcn1 −/− outward holding current and mEPSC kinetics were similar (Supplementary Table 1 ). The average somatic, but not dendritic, Hcn1 −/− mEPSC amplitudes were smaller than those of wild types ( Supplementary Table 1) . Notably, however, Hcn1 −/− mEPSC frequency was significantly greater than that of wild-type mice (Fig. 1b,c and Supplementary Table 1 ). Omitting ZD7288 from the internal pipette solution did not affect Hcn1 −/− mEPSC frequency or kinetics ( Supplementary Table 1 ). In addition, 15-min bath application of ZD7288 or zatebradine had no effect on somatic or dendritic Hcn1 −/− mEPSC frequency, amplitude or shape (Fig. 1b,c and Supplementary Fig. 1b) . These findings confirm that the enhanced wild-type mEPSC frequency caused by pharmacological blockers of I h is probably a result of HCN channel 
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-/-+ ZD , wild-type dendrites (n = 5), Hcn1 −/− soma (n = 6) and Hcn1 −/− dendrites (n = 5) with and without ZD7288. Superimposed on the histograms are Gaussian fits to demonstrate the peak amplitude of mEPSCs.
a r t I C l e S block and not nonspecific effects of the compounds 26 . These results also indicate that presynaptic HCN1 channels are likely to be involved in regulating excitatory spontaneous release from synapses localized to entorhinal cortical layer III neurons. We then recorded miniature inhibitory synaptic currents (mIPSCs) in the presence of glutamate receptor blockers to determine whether HCN channels were also present presynaptically on interneurons. In contrast with mEPSCs, somatic entorhinal cortical layer III mIPSCs were unaffected by 15-min bath application of ZD7288 ( Supplementary Fig. 2a ). Moreover, mIPSC frequency, amplitude and kinetics recorded from wild-type and Hcn1 −/− neurons did not differ ( Supplementary Fig. 2b) . These findings suggest that, in the entorhinal cortical, HCN1 channels selectively regulate glutamatergic synaptic release.
We next asked whether HCN1 channels were present at excitatory synapses targeting other principal entorhinal cortical neurons, particularly layer II stellate and layer V pyramids ( Fig. 2) . Application of ZD7288 had no effect on wild-type mEPSC frequency, amplitudes or kinetics recorded from the soma of these neurons (Fig. 2) . In addition, there were no differences between Hcn1 −/− and wild-type layer II and layer V mEPSCs ( Fig. 2) . As layer III pyramid dendrites are present in layer II and mEPSC frequency onto these is altered by pharmacological block of I h or HCN1 deletion ( Fig. 1c) , these results suggest that HCN1 channels are predominantly located at glutamatergic synaptic terminals contacting entorhinal cortical layer III pyramids.
The active zone of cortical terminals contains HCN1 channels
To determine whether HCN1 subunits are located on entorhinal cortical synaptic terminals, we carried out electron microscopy studies using a pre-embedding immunogold method (see Online Methods). We counted 2,752 particles in the medial entorhinal cortical from sections obtained from three wild-type mice. We found that 72.2 ± 0.8% of HCN1 immunogold particles were present along the extrasynaptic plasma membrane of dendritic shafts and spines ( Fig. 3) , consistent with the notion that HCN channels are largely present in entorhinal cortical dendrites. Notably, 27.8 ± 1.0% of immunogold particles were located at presynaptic sites ( Fig. 3) .
We further analyzed the distribution of presynaptic particles. Of 153 immunogold particles that were detected on synaptic terminals, the majority (129 of 153, 84%) of HCN1 immunogold particles were localized at terminals establishing asymmetrical excitatory synapses with pyramid dendritic spines ( Fig. 3b ). Of these, 71% (92 of 129) were present in the active zone and 29% (37 of 129) in presynaptic terminal membranes. In contrast, only 16% (24 of 153 particles in 8 synapses) were located in the axonal plasma membranes establishing symmetrical synapses ( Fig. 3c) . Notably, very few immunogold a r t I C l e S particles were observed in layer V (data not shown). No staining occurred if either the primary or secondary antibodies were omitted. Furthermore, no signal was detected in Hcn1 −/− sections obtained from four mice under either light ( Supplementary Fig. 3 ) or electron microscopy ( Fig. 3d) . These results, together with our electrophysiological results, suggest that HCN1 subunits are present at excitatory presynaptic terminals synapsing onto entorhinal cortical layer III neurons. These data are also consistent with our finding that ZD7288 only alters spontaneous excitatory synaptic transmission, and not inhibitory synaptic transmission, at layer III neurons ( Fig. 1 and Supplementary Figs. 1 and 2) .
Enhanced Ca 2+ dependence of Hcn1 −/− mEPSCs How do presynaptic HCN1 subunits regulate synaptic transmission at synapses targeting entorhinal cortical layer III neurons? Acute treatment of ZD7288 in wild-type neurons enhanced mEPSC frequency, suggesting that presynaptic HCN1 subunits do not affect synaptogenesis. Nevertheless, we compared the number of synapses in superficial entorhinal cortical layers (layers I-III) between wild-type and Hcn1 −/− mice using electron microscopy. From sections obtained from three wild-type and four Hcn1 −/− mice, no obvious differences in the number of synapses were detected ( Supplementary Fig. 4) , indicating that HCN1 subunits on synaptic terminals are likely to reduce synaptic transmission by directly affecting release probability. One possible mechanism by which presynaptic HCN1 channels may regulate synaptic transmission is by limiting Ca 2+ influx, as has been suggested to occur in dendrites 7 . Recent studies suggest that spontaneous as well as action potential-driven synaptic release may be dependent on Ca 2+ entry via voltage-gated Ca 2+ channels (VGCC) [30] [31] [32] [33] [34] . We therefore tested whether the mEPSCs recorded from layer III soma were Ca 2+ dependent. Replacement of Ca 2+ in the extracellular solution with an equal concentration of Mg 2+ reversibly reduced wild-type mEPSC frequency by 56.3 ± 5.1% (n = 9, P < 0.01) in 5 min ( Fig. 4a,b) . Substitution of Ca 2+ with Mg 2+ lowered Hcn1 −/− mEPSC frequency by 70.1 ± 3.6% (n = 9, P < 0.01; Fig. 4a ) in a reversible manner ( Fig. 4a,b ). This decrease in Hcn1 −/− mEPSC frequency was significantly (P = 0.04) greater than that in wild type. The amplitudes and the time constants of wild-type and Hcn1 −/− mEPSCs were not affected by replacing external Ca 2+ with Mg 2+ . The outward holding current, however, was reduced significantly to a similar extent in wild-type and Hcn1 −/− neurons (average holding current in the presence of Ca 2+ in wild-type and Hcn1 −/− cells = 30.0 ± 7.9 pA (n = 9) and 39.4 ± 20.0 pA (n = 9), respectively; holding current without Ca 2+ in wild-type and Hcn1 −/− pyramids = 5.0 ± 7.1 pA (n = 9, P < 0.05) and 10.0 ± 20.3 (n = 9, P < 0.05)). Given the larger Ca 2+ dependence of Hcn1 −/− mEPSCs, these results imply that presynaptic HCN1 channels regulate synaptic release by constraining Ca 2+ influx into terminals. Indeed, in the absence of extracellular Ca 2+ , bath application of ZD7288 no longer increased mEPSC frequency in wild-type mice (Fig. 4c) .
Presynaptic HCN channels limit T-type Ca 2+ channel activity
We next asked whether Ca 2+ entry through specific VGCCs contributes to generation of spontaneous mEPSCs and whether presynaptic HCN channels limit the activity of particular VGCCs. To investigate this, we first examined the effects of various pharmacological inhibitors of VGCCs on wild-type mEPSC frequency. The P/Q-type Ca 2+ channel blocker ω-agatoxin IVA 35, 36 (100 nM) and the N-type Ca 2+ channel inhibitor ω-conotoxin GVIA 35, 36 (100 nM) reduced wild-type mEPSC frequency by 47.3 ± 3.1% (n = 11; Supplementary Fig. 5 ) and 22.2 ± 4.7% (n = 9; Supplementary Fig. 5 ), respectively, without affecting amplitude or kinetics (Supplementary Table 2 ). The effects occurred within 10 min of bath application. ω-agatoxin IVA and ω-conotoxin GVIA coapplication decreased mEPSC frequency by 48.6 ± 5.5% (n = 6; Supplementary Fig. 5 ). In contrast, the L-type Ca 2+ channel inhibitor nifedipine 35, 36 (2 µM), the R-type Ca 2+ channel antagonist SNX-482 (200 nM) 37 , and the selective T-type Ca 2+ channel blockers mibefradil 36 (10 µM) TTA-P2 (1 µM) 38 and TTA-A2 (500 nM) 39 ,40 had no effect on wild-type mEPSCs ( Supplementary Fig. 5 and Supplementary Table 2 ). Wild-type mEPSC frequency inhibition in the presence of both ω-agatoxin IVA and ω-conotoxin GVIA was comparable to that resulting from removal of extracellular Ca 2+ (Fig. 4a,b ), suggesting that Ca 2+ influx via P/Q-and N-type channels generates Ca 2+ -dependent mEPSCs in these neurons. We then tested whether the ZD7288-induced enhancement in wildtype mEPSC frequency ( Fig. 1) could be occluded by pre-treatment with either ω-agatoxin IVA (100 nM) or ω-conotoxin GVIA (100 nM). Coapplication of ZD7288 with either ω-agatoxin IVA or ω-conotoxin GVIA or both increased mEPSC frequency in a comparable manner to that produced by ZD7288 alone (Fig. 5) . Moreover, in the presence of either nifedipine or SNX-482, ZD7288 also augmented mEPSC frequency ( Fig. 5) . However, the effects of ZD7288 on mEPSC frequency were prevented by pre-treatment with three different inhibitors of the low voltage-activated T-type Ca 2+ channels: mibefradil (10 µM) and the more potent and selective inhibitors TTA-P2 (1 µM) [38] [39] [40] and TTA-A2 (500 nM) 39, 40 (Fig. 5a,c) . The latter two have been shown to have no effects on other VGCCs in either heterologous expression systems 39, 40 or neurons 38 . These findings suggest that inhibition of HCN1 channels enhances excitatory synaptic transmission by altering T-type Ca 2+ channel activity.
To investigate this further, we explored the effects of T-type Ca 2+ channel blockers on Hcn1 −/− mEPSC frequency. In contrast with the results obtained in wild-type mice (Supplementary Fig. 5 ), mibefradil (10 µM), TTA-A2 (500 nM) and TTA-P2 (1 µM) significantly reduced Hcn1 −/− somatic mEPSC frequency by 35.7 ± 4.8% (n = 6, P < 0.05), 49.0 ± 4.8% (n = 7, P < 0.05) and 50.4 ± 4.4% (n = 6, P < 0.05), respectively (Fig. 5b,d) , but had no effect on amplitudes or time constants (Supplementary Table 3) . Given that mibefradil may also inhibit R-type Ca 2+ channels 41 , we tested the effects of SNX-482 (200 nM) on Hcn1 −/− mEPSCs. A 15-min application of SNX-482 had no effect on Hcn1 −/− mEPSCs (Fig. 5d) . To verify that T-type Ca 2+ channels expression is not modified in Hcn1 −/− mice, we carried out a western blot analysis using antibodies to Ca V 3.1 and Ca V 3.2 subunits. We were unable to detect any Ca V 3.1 protein expression in wild-type or Hcn1 −/− entorhinal cortex. However, bands corresponding to the
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-/neurons Hcn1 -/-+ TTA-A2 Hcn1 Figs. 6a and 7a) . Semi-quantitative analysis indicated that there was no difference in the expression of these bands between wild-type and Hcn1 −/− tissue (Supplementary Figs. 6a and 7a) . These findings indicate that a decrease in presynaptic HCN channel function leads to increased contribution of T-type Ca 2+ channel activity in modulating basal glutamatergic synaptic release.
HCN1 and Ca V 3.2 subunits coexist on synaptic terminals
Given that T-type Ca 2+ channel inhibitors prevent the effects of ZD7288, it is possible that these and HCN1 channels are present on the same presynaptic terminals. To investigate this, we used antibodies to Ca V 3.1 and Ca V 3.2 to examine the localization of Ca V 3 and HCN1 subunits in wild-type entorhinal cortex. For these particular experiments, the antibody to HCN1 was visualized using an immunoperoxidase reaction and the antibody to Ca v 3 was visualized by a silver-intensified immunogold reaction (see Online Methods). Consistent with the western blot data, Ca V 3.1 labeling could not be detected. However, Ca V 3.2 immunogold particles were present on asymmetrical synaptic terminals (Fig. 6a ) in sections obtained from three wild-type mice. Approximately 84% of these were present on axons pre-labeled with HCN1. HCN1 and Ca V 3.2 colabeling was noticeable on spines and dendrites as well (Supplementary Fig. 8 ). No Ca V 3.2 signal was identified on sections obtained from three Ca V 3.2 −/− (also known as Cacna1h) mice under either electron (Fig. 6a) or light microscopy (Supplementary Fig. 9 ). Moreover, no specific labeling was observed if the primary antibody was omitted or replaced with normal serum. In addition, the selective location of signals in structures labeled with only one or the other of the signaling products within the same section, as well as having side-by-side double-labeled structures, suggests that our procedures did not produce false-positive double-labeling results. These results therefore indicate that Ca V 3.2 and HCN1 subunits colocalize on synaptic terminals.
HCN channel inhibition does not affect Ca V 3.2 −/− mEPSCs
Given that T-type Ca 2+ channels and HCN channels can coexist on synaptic terminals (Fig. 6a) and T-type Ca 2+ channel blockers prevented the increase in mEPSC frequency by the HCN channel inhibitor ZD7288 (Fig. 5a,c) , we hypothesized that HCN channel blockers may not affect excitatory synaptic transmission in Ca V 3.2 −/− tissue. We therefore recorded mEPSCs from entorhinal cortical layer III neurons present in slices obtained from wild-type and Ca V 3.2 −/− mice 42 . As in previous experiments, ZD7288 (15 µM) was included in the patch pipette to inhibit postsynaptic HCN channels. Wild-type and Ca V 3.2 −/− mEPSC frequency, amplitude and kinetics were very similar (Supplementary Table 4 ), confirming that Ca V 3.2 channels do not modulate basal excitatory synaptic transmission. Notably, 15-min application of ZD7288 (15 µM) had little effect on Ca V 3.2 −/− mEPSCs (Fig. 6b) , but enhanced wild-type mEPSC frequency (Fig. 6b) . HCN1 protein levels were similar in wild-type and Ca V 3.2 −/− entorhinal cortex ( Supplementary  Figs. 6b and 7b) , indicating that the lack of effect of ZD7288 on Ca V 3.2 −/− mice is probably not a result of altered HCN1 expression. These results further support the notion that block of presynaptic HCN channels increases excitatory synaptic transmission by enhancing Ca 2+ entry via presynaptic Ca V 3.2 Ca 2+ channels.
Hyperpolarization activates presynaptic T-type Ca 2+ channels
We wondered how a loss of HCN channel function could augment T-type Ca 2+ channel activity. T-type Ca 2+ channels are low-threshold VGCCs that typically activate at potentials more positive than −75 mV 43, 44 . Native, as well as heterogously expressed Ca V 3.1-3.3, channels inactivate at potentials below −55 mV 43, 44 . Thus, there is a small window during which these channels are active. Given that T-type Ca 2+ channel blockers had no effect on basal wild-type mEPSC frequency (Supplementary Fig. 5 ) and that the basal frequencies between Ca V 3.2 −/− and wild-type mice were similar ( Supplementary Table 4 ), despite Ca V 3.2 immunogold particles being present on wild-type synaptic terminals (Fig. 6b) , it implies that these channels are inactive at rest. A reduction in HCN a r t I C l e S channel activity hyperpolarizes the membrane 1, 4 ; it is possible that RMP hyperpolarization relieves T-type Ca 2+ channel inactivation.
To investigate this hypothesis, we lowered the external K + concentration from 2.5 mM to 1.75 mM, which, using the Nernst equation, is estimated to hyperpolarize the RMP by ~10 mV. Indeed, reducing the external K + concentration resulted in entorhinal cortical layer III neuronal hyperpolarization by 7.3 ± 0.9 mV (n = 3). Furthermore, switching from 2.5 mM to 1.75 mM K + substantially enhanced wild-type mEPSC frequency within 10 min by 91.6 ± 14.1% (n = 6, P < 0.01; Fig. 7) . This was restored to near control levels by adding mibefradil 41 (10 µM; Fig. 7a ). Changing the external K + concentration from 2.5 mM to 1.75 mM in Hcn1 −/− slices, where the RMP is expected to be approximately −80 mV 4 , had little effect on mEPSC frequency (increase = −1.5 ± 3.6%, n = 5; Fig. 7b) , presumably as T-type Ca 2+ channel activity was not further altered. The outward holding current, mEPSC amplitude and kinetics were not affected by reducing external K + concentration in wild-type or Hcn1 −/− neurons (Fig. 7a,b) . These results provide additional support for the notion that T-type Ca 2+ channels are present on presynaptic terminals and can contribute to synaptic release under certain conditions.
HCN channels modulate evoked release onto layer III cells
We also asked whether HCN channels affect evoked release too. To determine this, we stimulated entorhinal cortical layer III distal dendrites to evoke pairs of EPSCs at 20 Hz in the absence and presence of 15 µM ZD7288 (see Online Methods). ZD7288 (15 µM) was included in the intracellular solution to block postsynaptic HCN channels. The amplitude of the first EPSC was adjusted between 50 to 100 pA (average amplitude, 71.3 ± 9.8 pA). Single EPSCs were also elicited in between pairs of EPSCs. Subtraction of these from the pairs of EPSCs was then used to elucidate the amplitudes of the first and second EPSCs in the pairs (Fig. 8) . The paired pulse ratio (PPR) was calculated as the amplitude of the second EPSC divided by the amplitude of the first.
Under control conditions, the average PPR was 0.9 ± 0.1 (n = 5; Fig. 8) . A 15-min bath application of ZD7288 significantly reduced the PPR to 0.7 ± 0.1 (n = 5, P < 0.01; Fig. 8 ) and increased the amplitude of the first evoked EPSC by 16.7 ± 5.8% (n = 6, P < 0.01). In addition, the square of the coefficient of variation (CV 2 ) decreased significantly to 0.7 ± 0.1 (P < 0.01). In contrast, ZD7288 (15 µM) had no effect on the PPR in Hcn1 −/− neurons (before ZD7288, 1.1 ± 0.2; after ZD7288,.1 ± 0.1; n = 6, P = 0.92). The lowered PPR and CV 2 in wild types indicate that synaptic release was enhanced by pharmacological block of HCN channels. These findings suggest that presynaptic HCN channels affect multiple modes of synaptic transmission.
DISCUSSION
We found that functional HCN1 channels are present on glutamatergic synaptic terminals synapsing onto entorhinal cortical layer III a r t I C l e S neurons, where they reduce spontaneous and evoked neurotransmitter release. These effects at least partly result from an altered availability of low-threshold, voltage-gated T-type Ca 2+ channels. Consistent with this, electron microscopy revealed that HCN1 and Ca V 3.2 subunits coexist on entorhinal cortical presynaptic terminals. Given that entorhinal cortical layer III neurons have been suggested to have roles in processes such as spatial navigation 22 and learning and memory 23 and that HCN channel function has been associated with modification of neural network rhythms and memory formation 8 , the dynamic modulation of synaptic inputs onto these neurons by HCN and T-type Ca 2+ channels may contribute to the regulation and modulation of these physiological states. Although HCN1 and HCN2 subunits are both expressed in the entorhinal cortical 3 , our results suggest that HCN1 subunits are likely to predominantly contribute to the formation of presynaptic HCN channels in glutamatergic synapses in the entorhinal cortical. Indeed, HCN1 subunit was detected on the active zone of wild-type excitatory synaptic terminals in the adult entorhinal cortical (Fig. 3) . Spontaneous glutamatergic synaptic transmission was also augmented in Hcn1 −/− slices and was not further affected by the nonselective HCN channel blockers ZD7288 ( Fig. 1) and zatebradine ( Supplementary  Fig. 1) . These agents, on the other hand, enhanced wild-type mEPSC frequency ( Fig. 1 and Supplementary Fig. 1 ). Furthermore, ZD7288 reduced the wild-type EPSC PPR (Fig. 8) . These findings indicate that pharmacological inhibition of HCN channels in normal tissue enhances glutamatergic synaptic transmission. As it has been suggested that ZD7288 depresses synaptic transmission independently of affecting HCN channels 26 , it is possible that the observed effects of ZD7288 might be underestimated ( Figs. 1 and 8) . Furthermore, the effects of zatebradine are dependent on HCN channels being open 27, 28 and the increase in mEPSC frequency in the presence of this compound may therefore be undervalued (Supplementary Fig. 1) . This might account for the increase in spontaneous release in Hcn1 −/− slices being much greater than that obtained with application of pharmacological blockers on wild-type slices ( Fig. 1 and Supplementary Fig. 1) . Notwithstanding, our results provide strong support for the involvement of HCN1 channels in modulating entorhinal cortical excitatory synaptic transmission.
Our results suggest that the presence of presynaptic HCN channels depolarizes the RMP, thereby restricting Ca 2+ entry via presynaptic T-type Ca 2+ channel activity and preventing glutamate release ( Figs. 4-7) . This suggests that presynaptic HCN channels may provide an additional regulatory mechanism for controlling synaptic release at these synapses. Thus, by affecting T-type Ca 2+ channel activity, modulation of HCN channel function by protein kinases or phosphatases will alter synaptic transmission at these synapses. Indeed, entorhinal cortical synaptic terminals may contain metabotropic glutamate receptors 45 , the activation of which could potentially reduce HCN channel function by altering kinase activity and induce plasticity 10 .
Altered T-type Ca 2+ channel activity by HCN channels has been suggested to occur in hippocampal dendrites as well 7 and it is therefore tempting to speculate that this might be a common mechanism by which these channels affect neuronal excitability. In invertebrate neurons, however, I h has been shown to increase excitatory synaptic release in a "non-ionic" way via a pathway involving actin depolymerization 18 . It is possible that this might occur in some mammalian interneurons too 16, 17 . This suggests that HCN channels in synaptic terminals may have multiple roles: a non-ionic function in which they modulate release by processes that involve changes in the cytoskeleton and a more conventional function in which they influence synaptic transmission by modifying the terminal RMP and the membrane resistivity, which has been shown to occur postsynaptically in dendrites 4, 24 . Which role they adopt may depend on their location in a synapse as well as their proximity to other proteins and ion channels.
Notably, the expression of HCN channel subunits and their effects on synaptic release were restricted to a subset of entorhinal cortical glutamatergic synaptic terminals ( Figs. 1-3) . This suggests that there may be factors that control expression of HCN channels in specific synapses and not in others. These synapses may belong to a particular cell type. Indeed, synapses targeting entorhinal cortical layer III neurons can originate from a number of sources, including other entorhinal cortical layer III neurons, and layer V and presubicular neurons. Given that HCN subunits have not been detected in the temporoammonic pathway, entorhinal cortical layer III pyramid axons or terminals synapsing onto CA1 dendrites (which belong to the temporoammonic pathway) 13 , it is likely that HCN channels are present on those synaptic terminals originating from entorhinal cortical layer V or pre-subiculum. Further work is required to resolve whether HCN subunit expressing synapses belong to a particular cell type and whether these synaptic terminals contain or lack proteins that regulate HCN channel expression. In addition, it remains to be determined whether other cortical synapses express functional presynaptic HCN and T-type Ca 2+ channels. Nonetheless, our results indicate that functional HCN channels can be present presynaptically as well as on pyramid cell dendrites in the mature cortex. Thus, there may be multiple means by which HCN channels can affect neural network excitability and, ultimately, processes such as learning and memory.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Slice preparation and electrophysiological experiments. Hcn1 +/− (ref. 46) and Ca V 3.2 +/− (ref. 42 ) breeding pairs were used to generate Hcn1 −/− , Ca V 3.2 −/− and wild-type littermates as described previously 4 . All electrophysiological experiments involving transgenic mice were done blindly. Entorhinal-hippocampal slices were obtained from 6-9-week-old Hcn11 −/− , Ca V 3.2 −/− and wild-type mice as described previously 4 . For electrophysiological recordings, slices were placed in a chamber containing external solution consisting of 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM glucose and 0.001 mM tetrodotoxin; bubbled with 95% O 2 /5% CO 2 (pH 7.2). Whole-cell voltage-clamp recordings were obtained from the soma and dendrites of entorhinal cortical neurons. The internal recording pipette solution for mEPSC recordings was composed of 120 mM KMeSO 4 , 20 mM KCl, 10 mM HEPES, 2 mM MgCl 2 , 0.2 mM EGTA, 4 mM Na 2 -ATP, 0.3 mM Tris-GTP, 14 mM Tris-phosphocreatine and 0.015 mM ZD7288; pH was adjusted to 7.3 with KOH. In some experiments, CsMeSO 4 was used instead of KMeSO 4 . To record mIPSCs, we replaced KMeSO 4 with KCl. Pipettes containing any of these internal solutions had resistances of 5-12 MΩ. In some recordings, 0.4% biocytin (wt/vol, Vector Laboratories) was included in the intracellular pipette solution. Slices were fixed in 4% (wt/vol) paraformaldehyde and stained with streptavidin Alexa-Fluor 294 conjugate (Molecular Probes) 24 h later as described previously 47 . For paired pulse recordings, tungsten electrodes (Biomedical Instruments) placed in entorhinal cortical layer I approximately 50-100 µm from entorhinal cortical layer III distal dendrites were used to elicit single and 20-Hz pairs of synaptic potentials in interleaved sequences every 30 s. The recordings were obtained using an Axopatch 200B amplifier (Molecular Devices), filtered at 1 kHz and sampled at 10 kHz. Series resistance was usually on the order of 10-30 MΩ and was approximately 70% compensated. Recordings were discarded if the series resistance increased by more than 20% during the course of the recordings. Data were acquired using pClamp 8.2 or pClamp 10.0 (Molecular Devices). data analysis. mEPSC and mIPSC recordings were analyzed using Mini-analysis program (v6.07, Synpatosoft). Events greater than 1.5 pA in amplitude (that is, all events above baseline noise level) and with rise times less than 2 ms were detected and used for analysis. Decay times and amplitudes of these events were obtained by fitting the averaged EPSC or IPSC with a single exponential equation
where I is the current amplitude at any given time (t), A is the peak amplitude of the EPSC or IPSC and τ is the decay time constant.
For paired-pulse experiments, data were analyzed using pClamp 10.0 (Molecular Devices). Interleaved single EPSCs evoked were subtracted from paired EPSCs to obtain the amplitude of the second EPSC (see Fig. 8 ). The PPR was then calculated as the amplitude of the second EPSC divided by the first. where SD PSC is the standard deviation of the EPSC amplitude, SD Baseline is the standard deviation of the background noise and Mean Amp is the mean amplitude of the EPSC. Group data are expressed as mean ± s.e.m. Statistical significance was determined using either paired or unpaired Student's t tests as appropriate.
Hcn1 and ca V 3.2 immunoreactivity experiments.
All experiments involving transgenic mice were performed blind. Procedures for the isolation of brain tissue from adult wild-type, Hcn1 −/− and Ca V 3.2 −/− mice for immunohistochemistry and immunoelectron microscopy experiments before and after embedding were described previously 48 . Three antibodies were used: a monoclonal antibody to HCN1 obtained from NeuroMab, a polyclonal antibody to HCN1 obtained from Alomone Labs and a monoclonal antibody to Ca V 3.2 obtained from Neuromab.
To examine the precise subcellular localization of HCN1 and Ca V 3.2 channels in the mouse entorhinal cortex, we used the single and double labeling techniques, as described previously 15 .
When a single primary antibody was used, it was visualized by the silverintensified immunogold reaction. In colabeling experiments, HCN1 immunoreactivity was visualized by the immunoperoxidase reaction, and Ca V 3.2 immunoreactivity was revealed with the silver-intensified immunogold reaction. Briefly, free-floating sections were obtained from 8-9-week-old mice. Sections were then incubated for 48 h with either HCN1 antibody alone or a mixture of two HCN1 and Ca v 3.2 antibodies, at a final protein concentration of 1-2 µg ml −1 each. After primary antibody incubation, the sections were incubated at 4 °C overnight with secondary antibodies: biotinylated goat antibody to rabbit (diluted 1:100, Vector Laboratories) and goat antibody to mouse (Fab fragment, diluted 1:100) coupled to 1.4-nm gold particles (Nanoprobes). After washes in Tris-buffered saline (Sigma), sections were washed in double-distilled water, followed by silver enhancement of the gold particles with an HQ Silver kit (Nanoprobes) for 8-10 min. Subsequently for double labeling, the sections were incubated for 4 h in the ABC complex (Vector Laboratories) in Tris-buffered saline and then washed in Tris buffer (0.05 M, pH 7.4). Peroxidase was visualized with DAB (0.05% (wt/vol) in Tris buffer, pH 7.4) using 0.01% (wt/vol) H 2 O 2 as substrate for 5-10 min. The sections were washed in phosphate buffer composed of 35.6 g L -1 Na 2 HPO 4 and 31.2 g L -1 NaH 2 PO 4 (0.1 M, pH 7.4) and then post-fixed with OsO 4 ((1% wt/vol) in 0.1 M phosphate buffer), followed by block-staining with uranyl acetate, dehydration in graded series of ethanol and flat-embedding on glass slides in Durcupan (Fluka) resin. Regions of interest were cut as 70-90-nm-thick sections using an ultramicrotome (Reichert Ultracut E, Leica). Ultrathin sections were mounted on 200 mesh nickel grids. Staining was performed on drops of 1% (wt/vol) aqueous uranyl acetate followed by Reynolds's lead citrate. Ultrastructural analyses were performed in a Jeol-1010 electron microscope. Unless otherwise stated, electron microscopic samples were obtained from three different mice and three blocks of each animal were cut for electron microscopy. Electron micrographs were captured with a CCD camera (Mega View III, Soft Imaging System). Digitized electron images were then modified for brightness and contrast by using Adobe PhotoShop CS1 (Mountain View) to optimize them for printing.
Quantitative analysis. To establish the relative abundance of HCN1 in entorhinal cortical layer III, we carried out immunolabeling quantification in 60-µm coronal slices as previously described 49 . Randomly selected areas were captured at a final magnification of 45,000×, and measurements covered a total section area of ~5,000 mm 2 . Dendritic shafts, dendritic spines and axon terminals were assessed for the presence of immunoparticles. The percentage of immunoparticles for HCN1 at post-and presynaptic sites was calculated. estimation of number of synapses. 6-9-week-old mice were anesthetized and killed by transcardial perfusion of 3% (wt/vol) glutaraldehyde in 0.05 M sodium cacodylate buffer (pH 7.4). The brains were removed and incubated in 1% OsO 4 for 3 h at 4 °C. The tissue was then washed with distilled water followed by 70% ethanol, 90% ethanol and 100% ethanol. The region of interest was then embedded in a beam capsule using a neat araldite CY212 resin mixture and polymerized for 3 d at 60 °C. Ultrathin sections were cut on a Reichert UCT at 85 nm using a Diatome Ultra diamond knife and collected on 400 mesh copper grids. Sections were subsequently stained was with 25% uranyl acetate in methanol and Reynolds lead citrate and imaged using a Phillips CM 10 TEM. Electron micrographs were captured using a high-sensitivity digital camera and synapses were counted from digital images. western blot analysis. Entorhinal cortical samples from 6-8-week-old wild-type and Hcn1 −/− or Ca V 3.2 −/− mice were homogenized using a syringe and sonicated for 10 s in 50 mM Tris pH 7.4, 50 mM NaCl, 2 mM EDTA and 25 mM N-ethylmaleimide, with complete protease inhibitors (Roche). The buffer was then supplemented with Igepal and SDS to final concentrations of 1% and 0.2% (wt/vol), respectively. Samples were kept on ice for 30-45 min and centrifuged for 30 min at 60,000g. The pellet was discarded and the supernatant kept for SDS-PAGE analysis. The protein concentration of each sample was determined using a Bradford-based assay (Bio-Rad). We supplemented 50 µg of total protein with gel loading buffer (50 mM Tris (pH 7.4), 100 mM dithiothreitol (DTT), 2% (wt/vol) SDS, 0.02% (wt/vol) bromophenol blue, 2% (wt/vol) glycerol), loaded this onto a 3-8% Tris-acetate gel and subjected it to SDS-PAGE following the manufacturer's instructions (Invitrogen). The transfer was performed on a PVDF membrane in a semi-dry chamber (Bio-Rad). A slice of the membrane containing proteins
